Quantitative trait loci, genes, and polymorphisms that regulate bone mineral density in mouse

Genomics

Volumn 93, Issue 5, 2009, Pages 401-414

  Xiong, Qing ^a,c   Jiao, Yan ^a   Hasty, Karen A ^a   Canale, S Terry ^a   Stuart, John M ^a   Beamer, Wesley G ^b   Deng, Hong Wen ^d   Baylink, David ^e   Gu, Weikuan ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b JACKSON LABORATORY   (United States)

^c SOUTHWEST UNIVERSITY   (China)

^d UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^e LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BMD; Gene; Mouse; Polymorphism; QTL

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ALDEHYDE DEHYDROGENASE; BONE MORPHOGENETIC PROTEIN 2; BRAIN NATRIURETIC PEPTIDE; CANNABINOID 2 RECEPTOR; CATALASE; CD38 ANTIGEN; DUFFY ANTIGEN RECEPTOR FOR CHEMOKINE; GAP JUNCTION PROTEIN ALPHA 4; GELATINASE B; GENE PRODUCT; GERANYLTRANSFERASE; INTERLEUKIN 10; LEPTIN RECEPTOR; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; NUCLEAR RECEPTOR COACTIVATOR 3; OSTEOCALCIN; PARATHYROID HORMONE RECEPTOR 1; PERILIPIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLEXIN A2; PROCOLLAGEN LYSINE 2 OXOGLUTARATE 5 DIOXYGENASE 1; PYROGLUTAMYLARGINYLPHENYLALANINAMIDE; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; STEM CELL FACTOR; SULFOTRANSFERASE 1E1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 1B; UNCLASSIFIED DRUG; VITAMIN K DEPENDENT GAMMA GLUTAMYL CARBOXYLASE;

BONE DENSITY; CHROMOSOME 1; CHROMOSOME 10; CHROMOSOME 11; CHROMOSOME 12; CHROMOSOME 13; CHROMOSOME 14; CHROMOSOME 15; CHROMOSOME 16; CHROMOSOME 17; CHROMOSOME 18; CHROMOSOME 19; CHROMOSOME 2; CHROMOSOME 3; CHROMOSOME 4; CHROMOSOME 5; CHROMOSOME 6; CHROMOSOME 7; CHROMOSOME 8; CHROMOSOME 9; GENETIC POLYMORPHISM; MOUSE; NONHUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; REVIEW; X CHROMOSOME; Y CHROMOSOME;

ANIMALS; BONE DENSITY; GENE ORDER; MICE; POLYMORPHISM, GENETIC; QUANTITATIVE TRAIT LOCI;

EID: 64149104990     PISSN: 08887543     EISSN: 10898646     Source Type: Journal    
DOI: 10.1016/j.ygeno.2008.12.008     Document Type: Review

References (207)

1. Kanis J.A., Melton III L.J., Christiansen C., Johnston C.C., and Khaltaev N. The diagnosis of osteoporosis. J. Bone Miner. Res. 9 (1994) 1137-1141
2. Duncan E.L., Cardon L.R., Sinsheimer J.S., Wass J.A., and Brown M.A. Site and gender specificity of inheritance of bone mineral density. J. Bone Miner. Res. 18 (2003) 1531-1538
3. Pocock N.A., Eisman J.A., Hopper J.L., Yeates M.G., Sambrook P.N., and Eberl S. Genetic determinants of bone mass in adults. A twin study. J. Clin. Invest. 80 (1987) 706-710
4. Gueguen R., Jouanny P., Guillemin F., Kuntz C., Pourel J., and Siest G. Segregation analysis and variance components analysis of bone mineral density in healthy families. J. Bone Miner. Res. 10 (1995) 2017-2022
5. Howard G.M., Nguyen T.V., Harris M., Kelly P.J., and Eisman J.A. Genetic and environmental contributions to the association between quantitative ultrasound and bone mineral density measurements: a twin study. J. Bone Miner. Res. 13 (1998) 1318-1327
6. Glazier A.M., Nadeau J.H., and Aitman T.J. Finding genes that underlie complex traits. Science 298 (2002) 2345-2349
7. Abiola O., Angel J.M., Avner P., Bachmanov A.A., Belknap J.K., Bennett B., Blankenhorn E.P., Blizard D.A., Bolivar V., Brockmann G.A., Buck K.J., Bureau J.F., Casley W.L., Chesler E.J., Cheverud J.M., Churchill G.A., Cook M., Crabbe J.C., Crusio W.E., Darvasi A., de Haan G., Dermant P., Doerge R.W., Elliot R.W., Farber C.R., Flaherty L., Flint J., Gershenfeld H., Gibson J.P., Gu J., Gu W., Himmelbauer H., Hitzemann R., Hsu H.C., Hunter K., Iraqi F.F., Jansen R.C., Johnson T.E., Jones B.C., Kempermann G., Lammert F., Lu L., Manly K.F., Matthews D.B., Medrano J.F., Mehrabian M., Mittlemann G., Mock B.A., Mogil J.S., Montagutelli X., Morahan G., Mountz J.D., Nagase H., Nowakowski R.S., O'Hara B.F., Osadchuk A.V., Paigen B., Palmer A.A., Peirce J.L., Pomp D., Rosemann M., Rosen G.D., Schalkwyk L.C., Seltzer Z., Settle S., Shimomura K., Shou S., Sikela J.M., Siracusa L.D., Spearow J.L., Teuscher C., Threadgill D.W., Toth L.A., Toye A.A., Vadasz C., Van Zant G., Wakeland E., Williams R.W., Zhang H.G., and Zou F. The nature and identification of quantitative trait loci: a community's view. Nat. Rev., Genet. 4 (2003) 911-916
8. Edderkaoui B., Baylink D.J., Beamer W.G., Wergedal J.E., Porte R., Chaudhuri A., and Mohan S. Identification of mouse Duffy antigen receptor for chemokines (Darc) as a BMD QTL gene. Genome Res. 17 (2007) 577-585
9. Klein R.F., Allard J., Avnur Z., Nikolcheva T., Rotstein D., Carlos A.S., Shea M., Waters R.V., Belknap J.K., Peltz G., and Orwoll E.S. Regulation of bone mass in mice by the lipoxygenase gene Alox15. Science 303 (2004) 229-232
10. Nakanishi R., Shimizu M., Mori M., Akiyama H., Okudaira S., Otsuki B., Hashimoto M., Higuchi K., Hosokawa M., Tsuboyama T., and Nakamura T. Secreted frizzled-related protein 4 is a negative regulator of peak BMD in SAMP6 mice. J. Bone Miner. Res. 21 (2006) 1713-1721
11. Huang Q.Y., and Kung A.W. The association of common polymorphisms in the QPCT gene with bone mineral density in the Chinese population. J. Hum. Genet. 52 (2007) 757-762
12. Xiong Q., Qiu Y., and Gu W. PGMapper: a web-based tool linking phenotype to genes. Bioinformatics 24 (2008) 1011-1013
13. Shultz K.L., Donahue L.R., Bouxsein M.L., Baylink D.J., Rosen C.J., and Beamer W.G. Congenic strains of mice for verification and genetic decomposition of quantitative trait loci for femoral bone mineral density. J. Bone Miner. Res. 18 (2003) 175-185
14. Beamer W.G., Shultz K.L., Churchill G.A., Frankel W.N., Baylink D.J., Rosen C.J., and Donahue L.R. Quantitative trait loci for bone density in C57BL/6J and CAST/EiJ inbred mice. Mamm. Genome 10 (1999) 1043-1049
15. Koh J.M., Park B.L., Kim D.J., Kim G.S., Cheong H.S., Kim T.H., Hong J.M., Shin H.I., Park E.K., Kim S.Y., and Shin H.D. Identification of novel RANK polymorphisms and their putative association with low BMD among postmenopausal women. Osteoporos. Int. 18 (2007) 323-331
16. Park B.L., Han I.K., Lee H.S., Kim L.H., Kim S.J., Shin J.S., Kim S.Y., and Shin H.D. Association of interleukin 10 haplotype with low bone mineral density in Korean postmenopausal women. J. Biochem. Mol. Biol. 37 (2004) 691-699
17. Lee W.Y., Rhee E.J., Oh K.W., Kim S.Y., Jung C.H., Yun E.J., Baek K.H., Kang M.I., and Kim S.W. Identification of adiponectin and its receptors in human osteoblast-like cells and association of T45G polymorphism in exon 2 of adiponectin gene with lumbar spine bone mineral density in Korean women. Clin. Endocrinol. (Oxf.) 65 (2006) 631-637
18. Tang C.H., Hsu T.L., Lin W.W., Lai M.Z., Yang R.S., Hsieh S.L., and Fu W.M. Attenuation of bone mass and increase of osteoclast formation in decoy receptor 3 transgenic mice. J Biol Chem 282 (2007) 2346-2354
19. Kano K., Marin de Evsikova C., Young J., Wnek C., Maddatu T.P., Nishina P.M., and Naggert J.K. A novel dwarfism with gonadal dysfunction due to loss-of-function allele of the collagen receptor gene, Ddr2, in the mouse. Mol. Endocrinol. 22 (2008) 1866-1880
20. Panupinthu N., Rogers J.T., Zhao L., Solano-Flores L.P., Possmayer F., Sims S.M., and Dixon S.J. P2X7 receptors on osteoblasts couple to production of lysophosphatidic acid: a signaling axis promoting osteogenesis. J. Cell Biol. 181 (2008) 859-871
21. Beamer W.G., Shultz K.L., Donahue L.R., Churchill G.A., Sen S., Wergedal J.R., Baylink D.J., and Rosen C.J. Quantitative trait loci for femoral and lumbar vertebral bone mineral density in C57BL/6J and C3H/HeJ inbred strains of mice. J. Bone Miner. Res. 16 (2001) 1195-1206
22. Takeshita S., Namba N., Zhao J.J., Jiang Y., Genant H.K., Silva M.J., Brodt M.D., Helgason C.D., Kalesnikoff J., Rauh M.J., Humphries R.K., Krystal G., Teitelbaum S.L., and Ross F.P. SHIP-deficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts. Nat. Med. 8 (2002) 943-949
23. Perrien D.S., Akel N.S., Edwards P.K., Carver A.A., Bendre M.S., Swain F.L., Skinner R.A., Hogue W.R., Nicks K.M., Pierson T.M., Suva L.J., and Gaddy D. Inhibin a is an endocrine stimulator of bone mass and strength. Endocrinology 148 (2007) 1654-1665
24. Wu M., Li J., Engleka K.A., Zhou B., Lu M.M., Plotkin J.B., and Epstein J.A. Persistent expression of Pax3 in the neural crest causes cleft palate and defective osteogenesis in mice. J. Clin. Invest. 118 (2008) 2076-2087
25. St-Jacques B., Hammerschmidt M., and McMahon A.P. Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev. 13 (1999) 2072-2086
26. Beamer W.G., Shultz K.L., Ackert-Bicknell C.L., Horton L.G., Delahunty K.M., Coombs H.F., Donahue L.R., Canalis E., and Rosen C.J. Genetic dissection of mouse distal chromosome 1 reveals three linked BMD QTLs with sex-dependent regulation of bone phenotypes. J. Bone Miner. Res. 22 (2007) 1187-1196
27. Ishimori N., Li R., Walsh K.A., Korstanje R., Rollins J.A., Petkov P., Pletcher M.T., Wiltshire T., Donahue L.R., Rosen C.J., Beamer W.G., Churchill G.A., and Paigen B. Quantitative trait loci that determine BMD in C57BL/6J and 129S1/SvImJ inbred mice. J. Bone Miner. Res. 21 (2006) 105-112
28. Hwang J.Y., Lee J.Y., Park M.H., Kim K.S., Kim K.K., Ryu H.J., Lee J.K., Han B.G., Kim J.W., Oh B., Kimm K., Park B.L., Shin H.D., Kim T.H., Hong J.M., Park E.K., Kim D.J., Koh J.M., Kim G.S., and Kim S.Y. Association of PLXNA2 polymorphisms with vertebral fracture risk and bone mineral density in postmenopausal Korean population. Osteoporos. Int. 17 (2006) 1592-1601
29. Edderkaoui B., Baylink D.J., Beamer W.G., Wergedal J.E., Dunn N.R., Shultz K.L., and Mohan S. Multiple genetic loci from CAST/EiJ chromosome 1 affect vBMD either positively or negatively in a C57BL/6J background. J. Bone Miner. Res. 21 (2006) 97-104
30. Klein O.F., Carlos A.S., Vartanian K.A., Chambers V.K., Turner E.J., Phillips T.J., Belknap J.K., and Orwoll E.S. Confirmation and fine mapping of chromosomal regions influencing peak bone mass in mice. J. Bone Miner. Res. 16 (2001) 1953-1961
31. Masinde G.L., Li X., Gu W., Wergedal J., Mohan S., and Baylink D.J. Quantitative trait loci for bone density in mice: the genes determining total skeletal density and femur density show little overlap in F2 mice. Calcif. Tissue Int. 71 (2002) 421-428
32. Klein R.F., Mitchell S.R., Phillips T.J., Belknap J.K., and Orwoll E.S. Quantitative trait loci affecting peak bone mineral density in mice. J. Bone Miner. Res. 13 (1998) 1648-1656
33. Scillitani A., Jang C., Wong B.Y., Hendy G.N., and Cole D.E. A functional polymorphism in the PTHR1 promoter region is associated with adult height and BMD measured at the femoral neck in a large cohort of young caucasian women. Hum. Genet. 119 (2006) 416-421
34. Vilarino-Guell C., Miles L.J., Duncan E.L., Ralston S.H., Compston J.E., Cooper C., Langdahl B.L., Maclelland A., Pols H.A., Reid D.M., Uitterlinden A.G., Steer C.D., Tobias J.H., Wass J.A., and Brown M.A. PTHR1 polymorphisms influence BMD variation through effects on the growing skeleton. Calcif. Tissue Int. 81 (2007) 270-278
35. Xiao L., Naganawa T., Obugunde E., Gronowicz G., Ornitz D.M., Coffin J.D., and Hurley M.M. Stat1 controls postnatal bone formation by regulating fibroblast growth factor signaling in osteoblasts. J. Biol. Chem. 279 (2004) 27743-27752
36. Salih D.A., Mohan S., Kasukawa Y., Tripathi G., Lovett F.A., Anderson N.F., Carter E.J., Wergedal J.E., Baylink D.J., and Pell J.M. Insulin-like growth factor-binding protein-5 induces a gender-related decrease in bone mineral density in transgenic mice. Endocrinology 146 (2005) 931-940
37. Hamrick M.W., Pennington C., and Byron C.D. Bone architecture and disc degeneration in the lumbar spine of mice lacking GDF-8 (myostatin). J. Orthop. Res. 21 (2003) 1025-1032
38. Dobreva G., Chahrour M., Dautzenberg M., Chirivella L., Kanzler B., Farinas I., Karsenty G., and Grosschedl R. SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation. Cell 125 (2006) 971-986
39. Sheu Y.T., Zmuda J.M., Cauley J.A., Moffett S.P., Rosen C.J., Ishwad C., and Ferrell R.E. Nuclear receptor coactivator-3 alleles are associated with serum bioavailable testosterone, insulin-like growth factor-1, and vertebral bone mass in men. J. Clin. Endocrinol. Metab. 91 (2006) 307-312
40. Yamada Y., Ando F., Niino N., and Shimokata H. Association of a polymorphism of the matrix metalloproteinase-9 gene with bone mineral density in Japanese men. Metabolism 53 (2004) 135-137
41. Yamada T., Kawano H., Koshizuka Y., Fukuda T., Yoshimura K., Kamekura S., Saito T., Ikeda T., Kawasaki Y., Azuma Y., Ikegawa S., Hoshi K., Chung U.I., Nakamura K., Kato S., and Kawaguchi H. Carminerin contributes to chondrocyte calcification during endochondral ossification. Nat. Med. 12 (2006) 665-670
42. Benes H., Weinstein R.S., Zheng W., Thaden J.J., Jilka R.L., Manolagas S.C., and Shmookler Reis R.J. Chromosomal mapping of osteopenia-associated quantitative trait loci using closely related mouse strains. J. Bone Miner. Res. 15 (2000) 626-633
43. Zhang Q., Qiu P., Arreaza M.G., Simon J.S., Golovko A., Laverty M., Vassileva G., Gustafson E.L., Rojas-Triana A., Bober L.A., Hedrick J.A., Monsma Jr. F.J., Greene J.R., Bayne M.L., and Murgolo N.J. P518/Qrfp sequence polymorphisms in SAMP6 osteopenic mouse. Genomics 90 (2007) 629-635
44. Baribault H., Danao J., Gupte J., Yang L., Sun B., Richards W., and Tian H. The G-protein-coupled receptor GPR103 regulates bone formation. Mol. Cell. Biol. 26 (2006) 709-717
45. Choi J.W., and Pai S.H. Associations between ABO blood groups and osteoporosis in postmenopausal women. Ann. Clin. Lab. Sci. 34 (2004) 150-153
46. Drake T.A., Schadt E., Hannani K., Kabo J.M., Krass K., Colinayo V., Greaser III L.E., Goldin J., and Lusis A.J. Genetic loci determining bone density in mice with diet-induced atherosclerosis. Physiol. Genomics 5 (2001) 205-215
47. Saftig P., Hartmann D., Lullmann-Rauch R., Wolff J., Evers M., Koster A., Hetman M., von Figura K., and Peters C. Mice deficient in lysosomal acid phosphatase develop lysosomal storage in the kidney and central nervous system. J. Biol. Chem. 272 (1997) 18628-18635
48. Gollner H., Dani C., Phillips B., Philipsen S., and Suske G. Impaired ossification in mice lacking the transcription factor Sp3. Mech. Dev. 106 (2001) 77-83
49. Choi J.Y., Shin C.S., Hong Y.C., and Kang D. Single-nucleotide polymorphisms and haplotypes of bone morphogenetic protein genes and peripheral bone mineral density in young Korean men and women. Calcif. Tissue Int. 78 (2006) 203-211
50. Styrkarsdottir U., Cazier J.B., Kong A., Rolfsson O., Larsen H., Bjarnadottir E., Johannsdottir V.D., Sigurdardottir M.S., Bagger Y., Christiansen C., Reynisdottir I., Grant S.F., Jonasson K., Frigge M.L., Gulcher J.R., Sigurdsson G., and Stefansson K. Linkage of osteoporosis to chromosome 20p12 and association to BMP2. PLoS Biol. 1 (2003) E69
51. Oh B., Kim S.Y., Kim D.J., Lee J.Y., Lee J.K., Kimm K., Park B.L., Shin H.D., Kim T.H., Park E.K., Koh J.M., and Kim G.S. Associations of catalase gene polymorphisms with bone mineral density and bone turnover markers in postmenopausal women. J. Med. Genet. 44 (2007) e62
52. Vidal C., Galea R., Brincat M., and Anastasi A.X. Linkage to chromosome 11p12 in two Maltese families with a highly penetrant form of osteoporosis. Eur. J. Hum. Genet. 15 (2007) 800-809
53. Lomaga M.A., Yeh W.C., Sarosi I., Duncan G.S., Furlonger C., Ho A., Morony S., Capparelli C., Van G., Kaufman S., van der Heiden A., Itie A., Wakeham A., Khoo W., Sasaki T., Cao Z., Penninger J.M., Paige C.J., Lacey D.L., Dunstan C.R., Boyle W.J., Goeddel D.V., and Mak T.W. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev. 13 (1999) 1015-1024
54. Fitzpatrick L.A., Buzas E., Gagne T.J., Nagy A., Horvath C., Ferencz V., Mester A., Kari B., Ruan M., Falus A., and Barsony J. Targeted deletion of histidine decarboxylase gene in mice increases bone formation and protects against ovariectomy-induced bone loss. Proc. Natl Acad. Sci. U. S. A. 100 (2003) 6027-6032
55. Johnson K.R., Marden C.C., Ward-Bailey P., Gagnon L.H., Bronson R.T., and Donahue L.R. Congenital hypothyroidism, dwarfism, and hearing impairment caused by a missense mutation in the mouse dual oxidase 2 gene, Duox2. Mol. Endocrinol. 21 (2007) 1593-1602
56. Gazzerro E., Smerdel-Ramoya A., Zanotti S., Stadmeyer L., Durant D., Economides A.N., and Canalis E. Conditional deletion of gremlin causes a transient increase in bone formation and bone mass. J. Biol. Chem. 282 (2007) 31549-31557
57. Montero A., Okada Y., Tomita M., Ito M., Tsurukami H., Nakamura T., Doetschman T., Coffin J.D., and Hurley M.M. Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J. Clin. Invest. 105 (2000) 1085-1093
58. Li X., Liu P., Liu W., Maye P., Zhang J., Zhang Y., Hurley M., Guo C., Boskey A., Sun L., Harris S.E., Rowe D.W., Ke H.Z., and Wu D. Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation. Nat. Genet. 37 (2005) 945-952
59. Bullock S.L., Fletcher J.M., Beddington R.S., and Wilson V.A. Renal agenesis in mice homozygous for a gene trap mutation in the gene encoding heparan sulfate 2-sulfotransferase. Genes Dev. 12 (1998) 1894-1906
60. Abrahamsen B., Madsen J.S., Tofteng C.L., Stilgren L., Bladbjerg E.M., Kristensen S.R., Brixen K., and Mosekilde L. A common methylenetetrahydrofolate reductase (C677T) polymorphism is associated with low bone mineral density and increased fracture incidence after menopause: longitudinal data from the Danish osteoporosis prevention study. J. Bone Miner. Res. 18 (2003) 723-729
61. Miyao M., Morita H., Hosoi T., Kurihara H., Inoue S., Hoshino S., Shiraki M., Yazaki Y., and Ouchi Y. Association of methylenetetrahydrofolate reductase (MTHFR) polymorphism with bone mineral density in postmenopausal Japanese women. Calcif. Tissue Int. 66 (2000) 190-194
62. Albagha O.M., Tasker P.N., McGuigan F.E., Reid D.M., and Ralston S.H. Linkage disequilibrium between polymorphisms in the human TNFRSF1B gene and their association with bone mass in perimenopausal women. Hum. Mol. Genet. 11 (2002) 2289-2295
63. Tasker P.N., Albagha O.M., Masson C.B., Reid D.M., and Ralston S.H. Association between TNFRSF1B polymorphisms and bone mineral density, bone loss and fracture. Osteoporos. Int. 15 (2004) 903-908
64. Spotila L.D., Rodriguez H., Koch M., Adams K., Caminis J., Tenenhouse H.S., and Tenenhouse A. Association of a polymorphism in the TNFR2 gene with low bone mineral density. J. Bone Miner. Res. 15 (2000) 1376-1383
65. Tasker P.N., Macdonald H., Fraser W.D., Reid D.M., Ralston S.H., and Albagha O.M. Association of PLOD1 polymorphisms with bone mineral density in a population-based study of women from the UK. Osteoporos. Int. 17 (2006) 1078-1085
66. Kajita M., Ezura Y., Iwasaki H., Ishida R., Yoshida H., Kodaira M., Suzuki T., Hosoi T., Inoue S., Shiraki M., Orimo H., and Emi M. Association of the - 381T/C promoter variation of the brain natriuretic peptide gene with low bone-mineral density and rapid postmenopausal bone loss. J. Hum. Genet. 48 (2003) 77-81
67. Yamada Y., Ando F., and Shimokata H. Association of candidate gene polymorphisms with bone mineral density in community-dwelling Japanese women and men. Int. J. Mol. Med. 19 (2007) 791-801
68. Fairbrother U.L., Tanko L.B., Walley A.J., Christiansen C., Froguel P., and Blakemore A.I. Leptin receptor genotype at Gln223Arg is associated with body composition, BMD, and vertebral fracture in postmenopausal Danish women. J. Bone Miner. Res. 22 (2007) 544-550
69. van der Weyden L., Wei L., Luo J., Yang X., Birk D.E., Adams D.J., Bradley A., and Chen Q. Functional knockout of the matrilin-3 gene causes premature chondrocyte maturation to hypertrophy and increases bone mineral density and osteoarthritis. Am. J. Pathol. 169 (2006) 515-527
70. Costell M., Gustafsson E., Aszodi A., Morgelin M., Bloch W., Hunziker E., Addicks K., Timpl R., and Fassler R. Perlecan maintains the integrity of cartilage and some basement membranes. J. Cell Biol. 147 (1999) 1109-1122
71. Pilecka I., Patrignani C., Pescini R., Curchod M.L., Perrin D., Xue Y., Yasenchak J., Clark A., Magnone M.C., Zaratin P., Valenzuela D., Rommel C., and Hooft van Huijsduijnen R. Protein-tyrosine phosphatase H1 controls growth hormone receptor signaling and systemic growth. J. Biol. Chem. 282 (2007) 35405-35415
72. Koller D.L., Schriefer J., Sun Q., Shultz K.L., Donahue L.R., Rosen C.J., Foroud T., Beamer W.G., and Turner C.H. Genetic effects for femoral biomechanics, structure, and density in C57BL/6J and C3H/HeJ inbred mouse strains. J. Bone Miner. Res. 18 (2003) 1758-1765
73. Kim S.Y., Lee J.Y., Kim H.Y., Oh B., Kimm K., Kim H.L., Park B.L., Shin H.D., Park E.K., Koh J.M., and Kim G.S. Association of KIT gene polymorphisms with bone mineral density in postmenopausal Korean women. J. Hum. Genet. 52 (2007) 502-509
74. Drummond F.J., Mackrill J.J., O'Sullivan K., Daly M., Shanahan F., and Molloy M.G. CD38 is associated with premenopausal and postmenopausal bone mineral density and postmenopausal bone loss. J. Bone Miner. Metab. 24 (2006) 28-35
75. Yamaguchi J., Hasegawa Y., Kawasaki M., Masui T., Kanoh T., Ishiguro N., and Hamajima N. ALDH2 polymorphisms and bone mineral density in an elderly Japanese population. Osteoporos. Int. 17 (2006) 908-913
76. Lee S.A., Choi J.Y., Shin C.S., Hong Y.C., Chung H., and Kang D. SULT1E1 genetic polymorphisms modified the association between phytoestrogen consumption and bone mineral density in healthy Korean women. Calcif. Tissue Int. 79 (2006) 152-159
77. Jain A., Fedarko N.S., Collins M.T., Gelman R., Ankrom M.A., Tayback M., and Fisher L.W. Serum levels of matrix extracellular phosphoglycoprotein (MEPE) in normal humans correlate with serum phosphorus, parathyroid hormone and bone mineral density. J. Clin. Endocrinol. Metab. 89 (2004) 4158-4161
78. Eswarakumar V.P., and Schlessinger J. Skeletal overgrowth is mediated by deficiency in a specific isoform of fibroblast growth factor receptor 3. Proc. Natl Acad. Sci. U. S. A. 104 (2007) 3937-3942
79. Malaval L., Wade-Gueye N.M., Boudiffa M., Fei J., Zirngibl R., Chen F., Laroche N., Roux J.P., Burt-Pichat B., Duboeuf F., Boivin G., Jurdic P., Lafage-Proust M.H., Amedee J., Vico L., Rossant J., and Aubin J.E. Bone sialoprotein plays a functional role in bone formation and osteoclastogenesis. J. Exp. Med. 205 (2008) 1145-1153
80. Karreth F., Hoebertz A., Scheuch H., Eferl R., and Wagner E.F. The AP1 transcription factor Fra2 is required for efficient cartilage development. Development 131 (2004) 5717-5725
81. Safadi F.F., Thornton P., Magiera H., Hollis B.W., Gentile M., Haddad J.G., Liebhaber S.A., and Cooke N.E. Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. J. Clin. Invest. 103 (1999) 239-251
82. Kearns A.E., Donohue M.M., Sanyal B., and Demay M.B. Cloning and characterization of a novel protein kinase that impairs osteoblast differentiation in vitro. J. Biol. Chem. 276 (2001) 42213-42218
83. Koh J.M., Kim G.S., Oh B., Lee J.Y., Park B.L., Shin H.D., Hong J.M., Kim T.H., Kim S.Y., and Park E.K. Microphthalmia-associated transcription factor polymorphisms and association with bone mineral density of the proximal femur in postmenopausal women. Mol. Cells 23 (2007) 246-251
84. Kiel D.P., Demissie S., Dupuis J., Lunetta K.L., Murabito J.M., and Karasik D. Genome-wide association with bone mass and geometry in the Framingham Heart Study. BMC Med. Genet. 8 Suppl. 1 (2007) S14
85. Kinoshita H., Nakagawa K., Narusawa K., Goseki-Sone M., Fukushi-Irie M., Mizoi L., Yoshida H., Okano T., Nakamura T., Suzuki T., Inoue S., Orimo H., Ouchi Y., and Hosoi T. A functional single nucleotide polymorphism in the vitamin-K-dependent gamma-glutamyl carboxylase gene (Arg325Gln) is associated with bone mineral density in elderly Japanese women. Bone 40 (2007) 451-456
86. Zhang P., McGrath B., Li S., Frank A., Zambito F., Reinert J., Gannon M., Ma K., McNaughton K., and Cavener D.R. The PERK eukaryotic initiation factor 2 alpha kinase is required for the development of the skeletal system, postnatal growth, and the function and viability of the pancreas. Mol. Cell. Biol. 22 (2002) 3864-3874
87. Tsukamoto K., Orimo H., Hosoi T., Miyao M., Yoshida H., Watanabe S., Suzuki T., and Emi M. Association of bone mineral density with polymorphism of the human matrix Gla protein locus in elderly women. J. Bone Miner. Metab. 18 (2000) 27-30
88. Holmen S.L., Giambernardi T.A., Zylstra C.R., Buckner-Berghuis B.D., Resau J.H., Hess J.F., Glatt V., Bouxsein M.L., Ai M., Warman M.L., and Williams B.O. Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6. J. Bone Miner. Res. 19 (2004) 2033-2040
89. Sitara D., Razzaque M.S., Hesse M., Yoganathan S., Taguchi T., Erben R.G., Juppner H., and Lanske B. Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice. Matrix Biol. 23 (2004) 421-432
90. Miao D., He B., Karaplis A.C., and Goltzman D. Parathyroid hormone is essential for normal fetal bone formation. J. Clin. Invest. 109 (2002) 1173-1182
91. Smits P., Li P., Mandel J., Zhang Z., Deng J.M., Behringer R.R., de Crombrugghe B., and Lefebvre V. The transcription factors L-Sox5 and Sox6 are essential for cartilage formation. Dev. Cell 1 (2001) 277-290
92. Yamada Y., Ando F., and Shimokata H. Association of polymorphisms in forkhead box C2 and perilipin genes with bone mineral density in community-dwelling Japanese individuals. Int. J. Mol. Med. 18 (2006) 119-127
93. Bustamante M., Nogues X., Enjuanes A., Elosua R., Garcia-Giralt N., Perez-Edo L., Caceres E., Carreras R., Mellibovsky L., Balcells S., Diez-Perez A., and Grinberg D. COL1A1, ESR1, VDR and TGFB1 polymorphisms and haplotypes in relation to BMD in Spanish postmenopausal women. Osteoporos. Int. 18 (2007) 235-243
94. Langdahl B.L., Carstens M., Stenkjaer L., and Eriksen E.F. Polymorphisms in the transforming growth factor beta 1 gene and osteoporosis. Bone 32 (2003) 297-310
95. Langdahl B.L., Uitterlinden A.G., Ralston S.H., Trikalinos T.A., Balcells S., Brandi M.L., Scollen S., Lips P., Lorenc R., Obermayer-Pietsch B., Reid D.M., Armas J.B., Arp P.P., Bassiti A., Bustamante M., Husted L.B., Carey A.H., Perez Cano R., Dobnig H., Dunning A.M., Fahrleitner-Pammer A., Falchetti A., Karczmarewicz E., Kruk M., van Leeuwen J.P., Masi L., van Meurs J.B., Mangion J., McGuigan F.E., Mellibovsky L., Mosekilde L., Nogues X., Pols H.A., Reeve J., Renner W., Rivadeneira F., van Schoor N.M., and Ioannidis J.P. Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS study. Bone 42 (2007) 969-981
96. Long J.R., Liu P.Y., Liu Y.J., Lu Y., Shen H., Zhao L.J., Xiong D.H., and Deng H.W. APOE haplotypes influence bone mineral density in Caucasian males but not females. Calcif. Tissue Int. 75 (2004) 299-304
97. Andressoo J.O., Jans J., de Wit J., Coin F., Hoogstraten D., van de Ven M., Toussaint W., Huijmans J., Thio H.B., van Leeuwen W.J., de Boer J., Egly J.M., Hoeijmakers J.H., van der Horst G.T., and Mitchell J.R. Rescue of progeria in trichothiodystrophy by homozygous lethal Xpd alleles. PLoS Biol. 4 (2006) e322
98. Desai J., Shannon M.E., Johnson M.D., Ruff D.W., Hughes L.A., Kerley M.K., Carpenter D.A., Johnson D.K., Rinchik E.M., and Culiat C.T. Nell1-deficient mice have reduced expression of extracellular matrix proteins causing cranial and vertebral defects. Hum. Mol. Genet. 15 (2006) 1329-1341
99. Zhang M., Xuan S., Bouxsein M.L., von Stechow D., Akeno N., Faugere M.C., Malluche H., Zhao G., Rosen C.J., Efstratiadis A., and Clemens T.L. Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J. Biol. Chem. 277 (2002) 44005-44012
100. Napoli N., Villareal D.T., Mumm S., Halstead L., Sheikh S., Cagaanan M., Rini G.B., and Armamento-Villareal R. Effect of CYP1A1 gene polymorphisms on estrogen metabolism and bone density. J. Bone Miner. Res. 20 (2005) 232-239
101. Leelawattana R., Ziambaras K., Roodman-Weiss J., Lyss C., Wagner D., Klug T., Armamento-Villareal R., and Civitelli R. The oxidative metabolism of estradiol conditions postmenopausal bone density and bone loss. J. Bone Miner. Res. 15 (2000) 2513-2520
102. Koh J.M., Oh B., Lee J.Y., Lee J.K., Kimm K., Kim G.S., Park B.L., Cheong H.S., Shin H.D., Hong J.M., Kim T.H., Park E.K., and Kim S.Y. Association study of semaphorin 7a (sema7a) polymorphisms with bone mineral density and fracture risk in postmenopausal Korean women. J. Hum. Genet. 51 (2006) 112-117
103. Borton A.J., Frederick J.P., Datto M.B., Wang X.F., and Weinstein R.S. The loss of Smad3 results in a lower rate of bone formation and osteopenia through dysregulation of osteoblast differentiation and apoptosis. J. Bone Miner. Res. 16 (2001) 1754-1764
104. Li J.P., Gong F., Hagner-McWhirter A., Forsberg E., Abrink M., Kisilevsky R., Zhang X., and Lindahl U. Targeted disruption of a murine glucuronyl C5-epimerase gene results in heparan sulfate lacking L-iduronic acid and in neonatal lethality. J. Biol. Chem. 278 (2003) 28363-28366
105. Suh W.K., Wang S.X., Jheon A.H., Moreno L., Yoshinaga S.K., Ganss B., Sodek J., Grynpas M.D., and Mak T.W. The immune regulatory protein B7-H3 promotes osteoblast differentiation and bone mineralization. Proc. Natl Acad. Sci. U. S. A. 101 (2004) 12969-12973
106. St-Arnaud R., Dardenne O., Prud'homme J., Hacking S.A., and Glorieux F.H. Conventional and tissue-specific inactivation of the 25-hydroxyvitamin D-1alpha-hydroxylase (CYP27B1). J. Cell. Biochem. 88 (2003) 245-251
107. Yu H., Mohan S., Edderkaoui B., Masinde G.L., Davidson H.M., Wergedal J.E., Beamer W.G., and Baylink D.J. Detecting novel bone density and bone size quantitative trait loci using a cross of MRL/MpJ and CAST/EiJ inbred mice. Calcif. Tissue Int. 80 (2007) 103-110
108. Rivadeneira F., Houwing-Duistermaat J.J., Vaessen N., Vergeer-Drop J.M., Hofman A., Pols H.A., Van Duijn C.M., and Uitterlinden A.G. Association between an insulin-like growth factor I gene promoter polymorphism and bone mineral density in the elderly: the Rotterdam Study. J. Clin. Endocrinol. Metab. 88 (2003) 3878-3884
109. Yanovski J.A., Sovik K.N., Nguyen T.T., and Sebring N.G. Insulin-like growth factors and bone mineral density in African American and White girls. J. Pediatr. 137 (2000) 826-832
110. Miura Y., Miura M., Gronthos S., Allen M.R., Cao C., Uveges T.E., Bi Y., Ehirchiou D., Kortesidis A., Shi S., and Zhang L. Defective osteogenesis of the stromal stem cells predisposes CD18-null mice to osteoporosis. Proc. Natl Acad. Sci. U. S. A. 102 (2005) 14022-14027
111. Ylonen R., Kyronlahti T., Sund M., Ilves M., Lehenkari P., Tuukkanen J., and Pihlajaniemi T. Type XIII collagen strongly affects bone formation in transgenic mice. J. Bone Miner. Res. 20 (2005) 1381-1393
112. Levi G., Topilko P., Schneider-Maunoury S., Lasagna M., Mantero S., Cancedda R., and Charnay P. Defective bone formation in Krox-20 mutant mice. Development 122 (1996) 113-120
113. Wettschureck N., Lee E., Libutti S.K., Offermanns S., Robey P.G., and Spiegel A.M. Parathyroid-specific double knockout of Gq and G11 alpha-subunits leads to a phenotype resembling germline knockout of the extracellular Ca2+ -sensing receptor. Mol. Endocrinol. 21 (2007) 274-280
114. Urano T., Shiraki M., Fujita M., Hosoi T., Orimo H., Ouchi Y., and Inoue S. Association of a single nucleotide polymorphism in the lipoxygenase ALOX15 5′-flanking region (- 5229G/A) with bone mineral density. J. Bone Miner. Metab. 23 (2005) 226-230
115. Ichikawa S., Koller D.L., Johnson M.L., Lai D., Xuei X., Edenberg H.J., Klein R.F., Orwoll E.S., Hui S.L., Foroud T.M., Peacock M., and Econs M.J. Human ALOX12, but not ALOX15, is associated with BMD in white men and women. J. Bone Miner. Res. 21 (2006) 556-564
116. Mullin B.H., Spector T.D., Curtis C.C., Ong G.N., Hart D.J., Hakim A.J., Worthy T., and Wilson S.G. Polymorphisms in ALOX12, but not ALOX15, are significantly associated with BMD in postmenopausal women. Calcif. Tissue Int. 81 (2007) 10-17
117. Omasu F., Ezura Y., Kajita M., Ishida R., Kodaira M., Yoshida H., Suzuki T., Hosoi T., Inoue S., Shiraki M., Orimo H., and Emi M. Association of genetic variation of the RIL gene, encoding a PDZ-LIM domain protein and localized in 5q31.1, with low bone mineral density in adult Japanese women. J. Hum. Genet. 48 (2003) 342-345
118. Eriksson A.L., Lorentzon M., Mellstrom D., Vandenput L., Swanson C., Andersson N., Hammond G.L., Jakobsson J., Rane A., Orwoll E.S., Ljunggren O., Johnell O., Labrie F., Windahl S.H., and Ohlsson C. SHBG gene promoter polymorphisms in men are associated with serum sex hormone-binding globulin, androgen and androgen metabolite levels, and hip bone mineral density. J. Clin. Endocrinol. Metab. 91 (2006) 5029-5037
119. Mansergh F.C., Wells T., Elford C., Evans S.L., Perry M.J., Evans M.J., and Evans B.A. Osteopenia in Sparc (osteonectin)-deficient mice: characterization of phenotypic determinants of femoral strength and changes in gene expression. Physiol. Genomics 32 (2007) 64-73
120. Dennison E.M., Syddall H.E., Rodriguez S., Voropanov A., Day I.N., and Cooper C. Polymorphism in the growth hormone gene, weight in infancy, and adult bone mass. J. Clin. Endocrinol. Metab. 89 (2004) 4898-4903
121. Dennison E.M., Hindmarsh P.C., Kellingray S., Fall C.H., and Cooper C. Growth hormone predicts bone density in elderly women. Bone 32 (2003) 434-440
122. Suuriniemi M., Kovanen V., Mahonen A., Alen M., Wang Q., Lyytikainen A., and Cheng S. COL1A1 Sp1 polymorphism associates with bone density in early puberty. Bone 39 (2006) 591-597
123. Perez-Castrillon J.L., Justo I., Silva J., Sanz A., Martin-Escudero J.C., Igea R., Escudero P., Pueyo C., Diaz C., Hernandez G., and Duenas A. Relationship between bone mineral density and angiotensin converting enzyme polymorphism in hypertensive postmenopausal women. Am. J. Hypertens. 16 (2003) 233-235
124. Uitterlinden A.G., Arp P.P., Paeper B.W., Charmley P., Proll S., Rivadeneira F., Fang Y., van Meurs J.B., Britschgi T.B., Latham J.A., Schatzman R.C., Pols H.A., and Brunkow M.E. Polymorphisms in the sclerosteosis/van Buchem disease gene (SOST) region are associated with bone-mineral density in elderly whites. Am. J. Hum. Genet. 75 (2004) 1032-1045
125. Wu X.B., Li Y., Schneider A., Yu W., Rajendren G., Iqbal J., Yamamoto M., Alam M., Brunet L.J., Blair H.C., Zaidi M., and Abe E. Impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis in noggin-overexpressing mice. J. Clin. Invest. 112 (2003) 924-934
126. Lammert M., Friedman J.M., Roth H.J., Friedrich R.E., Kluwe L., Atkins D., Schooler T., and Mautner V.F. Vitamin D deficiency associated with number of neurofibromas in neurofibromatosis 1. J. Med. Genet. 43 (2006) 810-813
127. Haldeman R.J., Cooper L.F., Hart T.C., Phillips C., Boyd C., Lester G.E., and Wright J.T. Increased bone density associated with DLX3 mutation in the tricho-dento-osseous syndrome. Bone 35 (2004) 988-997
128. Watanuki M., Sakai A., Sakata T., Tsurukami H., Miwa M., Uchida Y., Watanabe K., Ikeda K., and Nakamura T. Role of inducible nitric oxide synthase in skeletal adaptation to acute increases in mechanical loading. J. Bone Miner. Res. 17 (2002) 1015-1025
129. O'Shea P.J., Bassett J.H., Sriskantharajah S., Ying H., Cheng S.Y., and Williams G.R. Contrasting skeletal phenotypes in mice with an identical mutation targeted to thyroid hormone receptor alpha1 or beta. Mol. Endocrinol. 19 (2005) 3045-3059
130. Bi W., Huang W., Whitworth D.J., Deng J.M., Zhang Z., Behringer R.R., and de Crombrugghe B. Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization. Proc. Natl Acad. Sci. U. S. A. 98 (2001) 6698-6703
131. Shimizu M., Higuchi K., Bennett B., Xia C., Tsuboyama T., Kasai S., Chiba T., Fujisawa H., Kogishi K., Kitado H., Kimoto M., Takeda N., Matsushita M., Okumura H., Serikawa T., Nakamura T., Johnson T.E., and Hosokawa M. Identification of peak bone mass QTL in a spontaneously osteoporotic mouse strain. Mamm. Genome 10 (1999) 81-87
132. Kung A.W., Lai B.M., Ng M.Y., Chan V., and Sham P.C. T-1213C polymorphism of estrogen receptor beta is associated with low bone mineral density and osteoporotic fractures. Bone 39 (2006) 1097-1106
133. Ichikawa S., Koller D.L., Peacock M., Johnson M.L., Lai D., Hui S.L., Johnston C.C., Foroud T.M., and Econs M.J. Polymorphisms in the estrogen receptor beta (ESR2) gene are associated with bone mineral density in Caucasian men and women. J. Clin. Endocrinol. Metab. 90 (2005) 5921-5927
134. van der Deure W.M., Uitterlinden A.G., Hofman A., Rivadeneira F., Pols H.A., Peeters R.P., and Visser T.J. Effects of serum TSH and FT4 levels and the TSHR-Asp727Glu polymorphism on bone: the Rotterdam Study. Clin. Endocrinol. (Oxf.) 68 (2008) 175-181
135. Abe E., Marians R.C., Yu W., Wu X.B., Ando T., Li Y., Iqbal J., Eldeiry L., Rajendren G., Blair H.C., Davies T.F., and Zaidi M. TSH is a negative regulator of skeletal remodeling. Cell 115 (2003) 151-162
136. Kammerer C.M., Schneider J.L., Cole S.A., Hixson J.E., Samollow P.B., O'Connell J.R., Perez R., Dyer T.D., Almasy L., Blangero J., Bauer R.L., and Mitchell B.D. Quantitative trait loci on chromosomes 2p, 4p, and 13q influence bone mineral density of the forearm and hip in Mexican Americans. J. Bone Miner. Res. 18 (2003) 2245-2252
137. Ralston S.H., Galwey N., MacKay I., Albagha O.M., Cardon L., Compston J.E., Cooper C., Duncan E., Keen R., Langdahl B., McLellan A., O'Riordan J., Pols H.A., Reid D.M., Uitterlinden A.G., Wass J., and Bennett S.T. Loci for regulation of bone mineral density in men and women identified by genome wide linkage scan: the FAMOS study. Hum. Mol. Genet. 14 (2005) 943-951
138. Guggenbuhl P., Deugnier Y., Boisdet J.F., Rolland Y., Perdriger A., Pawlotsky Y., and Chales G. Bone mineral density in men with genetic hemochromatosis and HFE gene mutation. Osteoporos. Int. 16 (2005) 1809-1814
139. Bose J., Grotewold L., and Ruther U. Pallister-Hall syndrome phenotype in mice mutant for Gli3. Hum. Mol. Genet. 11 (2002) 1129-1135
140. Ermakov S., Malkin I., Keter M., Kobyliansky E., and Livshits G. Family-based association study of ROR2 polymorphisms with an array of radiographic hand bone strength phenotypes. Osteoporos. Int. 18 (2007) 1683-1692
141. Mak K.K., Chen M.H., Day T.F., Chuang P.T., and Yang Y. Wnt/beta-catenin signaling interacts differentially with Ihh signaling in controlling endochondral bone and synovial joint formation. Development 133 (2006) 3695-3707
142. Hsu Y.H., Niu T., Terwedow H.A., Xu X., Feng Y., Li Z., Brain J.D., Rosen C.J., Laird N., and Xu X. Variation in genes involved in the RANKL/RANK/OPG bone remodeling pathway are associated with bone mineral density at different skeletal sites in men. Hum. Genet. 118 (2006) 568-577
143. Mencej S., Prezelj J., Kocijancic A., Ostanek B., and Marc J. Association of TNFSF11 gene promoter polymorphisms with bone mineral density in postmenopausal women. Maturitas 55 (2006) 219-226
144. Nakamichi Y., Shukunami C., Yamada T., Aihara K., Kawano H., Sato T., Nishizaki Y., Yamamoto Y., Shindo M., Yoshimura K., Nakamura T., Takahashi N., Kawaguchi H., Hiraki Y., and Kato S. Chondromodulin I is a bone remodeling factor. Mol. Cell. Biol. 23 (2003) 636-644
145. Mohan S., Kapoor A., Singgih A., Zhang Z., Taylor T., Yu H., Chadwick R.B., Chung Y.S., Donahue L.R., Rosen C., Crawford G.C., Wergedal J., and Baylink D.J. Spontaneous fractures in the mouse mutant sfx are caused by deletion of the gulonolactone oxidase gene, causing vitamin C deficiency. J. Bone Miner. Res. 20 (2005) 1597-1610
146. Zhou Z., Apte S.S., Soininen R., Cao R., Baaklini G.Y., Rauser R.W., Wang J., Cao Y., and Tryggvason K. Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc. Natl Acad. Sci. U. S. A. 97 (2000) 4052-4057
147. Haycraft C.J., Zhang Q., Song B., Jackson W.S., Detloff P.J., Serra R., and Yoder B.K. Intraflagellar transport is essential for endochondral bone formation. Development 134 (2007) 307-316
148. Zheng L., Baek H.J., Karsenty G., and Justice M.J. Filamin B represses chondrocyte hypertrophy in a Runx2/Smad3-dependent manner. J. Cell Biol. 178 (2007) 121-128
149. O'Shea P.J., Harvey C.B., Suzuki H., Kaneshige M., Kaneshige K., Cheng S.Y., and Williams G.R. A thyrotoxic skeletal phenotype of advanced bone formation in mice with resistance to thyroid hormone. Mol. Endocrinol. 17 (2003) 1410-1424
150. Bonyadi M., Waldman S.D., Liu D., Aubin J.E., Grynpas M.D., and Stanford W.L. Mesenchymal progenitor self-renewal deficiency leads to age-dependent osteoporosis in Sca-1/Ly-6A null mice. Proc. Natl Acad. Sci. U. S. A. 100 (2003) 5840-5845
151. Yang X., Matsuda K., Bialek P., Jacquot S., Masuoka H.C., Schinke T., Li L., Brancorsini S., Sassone-Corsi P., Townes T.M., Hanauer A., and Karsenty G. ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome. Cell 117 (2004) 387-398
152. Bonkowski M.S., Pamenter R.W., Rocha J.S., Masternak M.M., Panici J.A., and Bartke A. Long-lived growth hormone receptor knockout mice show a delay in age-related changes of body composition and bone characteristics. J. Gerontol. A, Biol. Sci. Med. Sci. 61 (2006) 562-567
153. Lemos M.C., Kotanko P., Christie P.T., Harding B., Javor T., Smith C., Eastell R., and Thakker R.V. A novel EXT1 splice site mutation in a kindred with hereditary multiple exostosis and osteoporosis. J. Clin. Endocrinol. Metab. 90 (2005) 5386-5392
154. Vidal C., Brincat M., and Xuereb Anastasi A. TNFRSF11B gene variants and bone mineral density in postmenopausal women in Malta. Maturitas 53 (2006) 386-395
155. Yagi M., Miyamoto T., Sawatani Y., Iwamoto K., Hosogane N., Fujita N., Morita K., Ninomiya K., Suzuki T., Miyamoto K., Oike Y., Takeya M., Toyama Y., and Suda T. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J. Exp. Med. 202 (2005) 345-351
156. Ho A.M., Johnson M.D., and Kingsley D.M. Role of the mouse ank gene in control of tissue calcification and arthritis. Science 289 (2000) 265-270
157. Subramaniam M., Gorny G., Johnsen S.A., Monroe D.G., Evans G.L., Fraser D.G., Rickard D.J., Rasmussen K., van Deursen J.M., Turner R.T., Oursler M.J., and Spelsberg T.C. TIEG1 null mouse-derived osteoblasts are defective in mineralization and in support of osteoclast differentiation in vitro. Mol. Cell. Biol. 25 (2005) 1191-1199
158. Sainz J., Van Tornout J.M., Loro M.L., Sayre J., Roe T.F., and Gilsanz V. Vitamin D-receptor gene polymorphisms and bone density in prepubertal American girls of Mexican descent. N. Engl. J. Med. 337 (1997) 77-82
159. Horst-Sikorska W., Kalak R., Wawrzyniak A., Marcinkowska M., Celczynska-Bajew L., and Slomski R. Association analysis of the polymorphisms of the VDR gene with bone mineral density and the occurrence of fractures. J. Bone Miner. Metab. 25 (2007) 310-319
160. Uitterlinden A.G., Ralston S.H., Brandi M.L., Carey A.H., Grinberg D., Langdahl B.L., Lips P., Lorenc R., Obermayer-Pietsch B., Reeve J., Reid D.M., Amedei A., Bassiti A., Bustamante M., Husted L.B., Diez-Perez A., Dobnig H., Dunning A.M., Enjuanes A., Fahrleitner-Pammer A., Fang Y., Karczmarewicz E., Kruk M., van Leeuwen J.P., Mavilia C., van Meurs J.B., Mangion J., McGuigan F.E., Pols H.A., Renner W., Rivadeneira F., van Schoor N.M., Scollen S., Sherlock R.E., and Ioannidis J.P. The association between common vitamin D receptor gene variations and osteoporosis: a participant-level meta-analysis. Ann. Intern. Med. 145 (2006) 255-264
161. Hustmyer F.G., Peacock M., Hui S., Johnston C.C., and Christian J. Bone mineral density in relation to polymorphism at the vitamin D receptor gene locus. J. Clin. Invest. 94 (1994) 2130-2134
162. Bennett C.N., Ouyang H., Ma Y.L., Zeng Q., Gerin I., Sousa K.M., Lane T.F., Krishnan V., Hankenson K.D., and MacDougald O.A. Wnt10b increases postnatal bone formation by enhancing osteoblast differentiation. J. Bone Miner. Res. 22 (2007) 1924-1932
163. Tsukamoto K., Orimo H., Hosoi T., Miyao M., Ota N., Nakajima T., Yoshida H., Watanabe S., Suzuki T., and Emi M. Association of bone mineral density with polymorphism of the human calcium-sensing receptor locus. Calcif. Tissue Int. 66 (2000) 181-183
164. Yang Y.J., Wang Y.B., Lei S.F., Long J.R., Shen H., Zhao L.J., Jiang D.K., Xiao S.M., Chen X.D., Chen Y., and Deng H.W. AHSG gene polymorphisms are associated with bone mineral density in Caucasian nuclear families. Eur. J. Epidemiol. 22 (2007) 527-532
165. Thomas G., Moffatt P., Salois P., Gaumond M.H., Gingras R., Godin E., Miao D., Goltzman D., and Lanctot C. Osteocrin, a novel bone-specific secreted protein that modulates the osteoblast phenotype. J. Biol. Chem. 278 (2003) 50563-50571
166. Lorentzon M., Eriksson A.L., Mellstrom D., and Ohlsson C. The COMT val158met polymorphism is associated with peak BMD in men. J. Bone Miner. Res. 19 (2004) 2005-2011
167. Lorentzon M., Eriksson A.L., Nilsson S., Mellstrom D., and Ohlsson C. Association between physical activity and BMD in young men is modulated by catechol-O-methyltransferase (COMT) genotype: the GOOD study. J. Bone Miner. Res. 22 (2007) 1165-1172
168. Furuta I., Kobayashi N., Fujino T., Kobamatsu Y., Shirogane T., Yaegashi M., Sakuragi N., Cho K., Yamada H., Okuyama K., and Minakami H. Bone mineral density of the lumbar spine is associated with TNF gene polymorphisms in early postmenopausal Japanese women. Calcif. Tissue Int. 74 (2004) 509-515
169. Wennberg P., Nordstrom P., Lorentzon R., Lerner U.H., and Lorentzon M. TNF-alpha gene polymorphism and plasma TNF-alpha levels are related to lumbar spine bone area in healthy female Caucasian adolescents. Eur. J. Endocrinol. 146 (2002) 629-634
170. Vaughan T., Pasco J.A., Kotowicz M.A., Nicholson G.C., and Morrison N.A. Alleles of RUNX2/CBFA1 gene are associated with differences in bone mineral density and risk of fracture. J. Bone Miner. Res. 17 (2002) 1527-1534
171. Bustamante M., Nogues X., Agueda L., Jurado S., Wesselius A., Caceres E., Carreras R., Ciria M., Mellibovsky L., Balcells S., Diez-Perez A., and Grinberg D. Promoter 2 -1025 T/C polymorphism in the RUNX2 gene is associated with femoral neck bmd in Spanish postmenopausal women. Calcif. Tissue Int. 81 (2007) 327-332
172. Pettersson U., Albagha O.M., Mirolo M., Taranta A., Frattini A., McGuigan F.E., Vezzoni P., Teti A., van Hul W., Reid D.M., Villa A., and Ralston S.H. Polymorphisms of the CLCN7 gene are associated with BMD in women. J. Bone Miner. Res. 20 (2005) 1960-1967
173. Zhou Z., Immel D., Xi C.X., Bierhaus A., Feng X., Mei L., Nawroth P., Stern D.M., and Xiong W.C. Regulation of osteoclast function and bone mass by RAGE. J. Exp. Med. 203 (2006) 1067-1080
174. Lu W., Shen X., Pavlova A., Lakkis M., Ward C.J., Pritchard L., Harris P.C., Genest D.R., Perez-Atayde A.R., and Zhou J. Comparison of Pkd1-targeted mutants reveals that loss of polycystin-1 causes cystogenesis and bone defects. Hum. Mol. Genet. 10 (2001) 2385-2396
175. Vogel W.F., Aszodi A., Alves F., and Pawson T. Discoidin domain receptor 1 tyrosine kinase has an essential role in mammary gland development. Mol. Cell. Biol. 21 (2001) 2906-2917
176. Tan X., Weng T., Zhang J., Wang J., Li W., Wan H., Lan Y., Cheng X., Hou N., Liu H., Ding J., Lin F., Yang R., Gao X., Chen D., and Yang X. Smad4 is required for maintaining normal murine postnatal bone homeostasis. J. Cell. Sci. 120 (2007) 2162-2170
177. Dai X.M., Zong X.H., Akhter M.P., and Stanley E.R. Osteoclast deficiency results in disorganized matrix, reduced mineralization, and abnormal osteoblast behavior in developing bone. J. Bone Miner. Res. 19 (2004) 1441-1451
178. Elefteriou F., Ahn J.D., Takeda S., Starbuck M., Yang X., Liu X., Kondo H., Richards W.G., Bannon T.W., Noda M., Clement K., Vaisse C., and Karsenty G. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434 (2005) 514-520
179. Yamada Y., Ando F., and Shimokata H. Association of polymorphisms in CYP17A1, MTP, and VLDLR with bone mineral density in community-dwelling Japanese women and men. Genomics 86 (2005) 76-85
180. Hu Y., Baud V., Delhase M., Zhang P., Deerinck T., Ellisman M., Johnson R., and Karin M. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase. Science 284 (1999) 316-320
181. Parsons C.A., Mroczkowski H.J., McGuigan F.E., Albagha O.M., Manolagas S., Reid D.M., Ralston S.H., and Shmookler Reis R.J. Interspecies synteny mapping identifies a quantitative trait locus for bone mineral density on human chromosome Xp22. Hum. Mol. Genet. 14 (2005) 3141-3148
182. Levy M.E., Parker R.A., Ferrell R.E., Zmuda J.M., and Greenspan S.L. Farnesyl diphosphate synthase: a novel genotype association with bone mineral density in elderly women. Maturitas 57 (2007) 247-252
183. Ota N., Nakajima T., Nakazawa I., Suzuki T., Hosoi T., Orimo H., Inoue S., Shirai Y., and Emi M. A nucleotide variant in the promoter region of the interleukin-6 gene associated with decreased bone mineral density. J. Hum. Genet. 46 (2001) 267-272
184. Chung H.W., Seo J.S., Hur S.E., Kim H.L., Kim J.Y., Jung J.H., Kim L.H., Park B.L., and Shin H.D. Association of interleukin-6 promoter variant with bone mineral density in pre-menopausal women. J. Hum. Genet. 48 (2003) 243-248
185. Kawano K., Ogata N., Chiano M., Molloy H., Kleyn P., Spector T.D., Uchida M., Hosoi T., Suzuki T., Orimo H., Inoue S., Nabeshima Y., Nakamura K., Kuro-o M., and Kawaguchi H. Klotho gene polymorphisms associated with bone density of aged postmenopausal women. J. Bone Miner. Res. 17 (2002) 1744-1751
186. Yamada Y., Ando F., Niino N., and Shimokata H. Association of polymorphisms of the androgen receptor and klotho genes with bone mineral density in Japanese women. J. Mol. Med. 83 (2005) 50-57
187. Koh J.M., Oh B., Lee J.Y., Lee J.K., Kimm K., Park B.L., Shin H.D., Lee I.K., Kim H.J., Hong J.M., Kim T.H., Kim G.S., Kim S.Y., and Park E.K. Association of FLT3 polymorphisms with low BMD and risk of osteoporotic fracture in postmenopausal women. J. Bone Miner. Res. 22 (2007) 1752-1758
188. Kim G.S., Koh J.M., Chang J.S., Park B.L., Kim L.H., Park E.K., Kim S.Y., and Shin H.D. Association of the OSCAR promoter polymorphism with BMD in postmenopausal women. J. Bone Miner. Res. 20 (2005) 1342-1348
189. Yamada Y., Ando F., Niino N., and Shimokata H. Association of a polymorphism of the dopamine receptor D4 gene with bone mineral density in Japanese men. J. Hum. Genet. 48 (2003) 629-633
190. Enjuanes A., Garcia-Giralt N., Supervia A., Nogues X., Ruiz-Gaspa S., Bustamante M., Mellibovsky L., Grinberg D., Balcells S., and Diez-Perez A. A new SNP in a negative regulatory region of the CYP19A1 gene is associated with lumbar spine BMD in postmenopausal women. Bone 38 (2006) 738-743
191. Hong X., Hsu Y.H., Terwedow H., Arguelles L.M., Tang G., Liu X., Zhang S., Xu X., and Xu X. CYP19A1 polymorphisms are associated with bone mineral density in Chinese men. Hum. Genet. 121 (2007) 491-500
192. Yamada Y., Ando F., Niino N., and Shimokata H. Association of a polymorphism of the CC chemokine receptor-2 gene with bone mineral density. Genomics 80 (2002) 8-12
193. Becherini L., Gennari L., Masi L., Mansani R., Massart F., Morelli A., Falchetti A., Gonnelli S., Fiorelli G., Tanini A., and Brandi M.L. Evidence of a linkage disequilibrium between polymorphisms in the human estrogen receptor alpha gene and their relationship to bone mass variation in postmenopausal Italian women. Hum. Mol. Genet. 9 (2000) 2043-2050
194. van Meurs J.B., Schuit S.C., Weel A.E., van der Klift M., Bergink A.P., Arp P.P., Colin E.M., Fang Y., Hofman A., van Duijn C.M., van Leeuwen J.P., Pols H.A., and Uitterlinden A.G. Association of 5′ estrogen receptor alpha gene polymorphisms with bone mineral density, vertebral bone area and fracture risk. Hum. Mol. Genet. 12 (2003) 1745-1754
195. Lai B.M., Cheung C.L., Luk K.D., and Kung A.W. Estrogen receptor alpha CA dinucleotide repeat polymorphism is associated with rate of bone loss in perimenopausal women and bone mineral density and risk of osteoporotic fractures in postmenopausal women. Osteoporos. Int. 19 (2008) 571-579
196. Lee H.J., Kim S.Y., Koh J.M., Bok J., Kim K.J., Kim K.S., Park M.H., Shin H.D., Park B.L., Kim T.H., Hong J.M., Park E.K., Kim D.J., Oh B., Kimm K., Kim G.S., and Lee J.Y. Polymorphisms and haplotypes of integrinalpha1 (ITGA1) are associated with bone mineral density and fracture risk in postmenopausal Koreans. Bone 41 (2007) 979-986
197. Ramesh Babu L., Wilson S.G., Dick I.M., Islam F.M., Devine A., and Prince R.L. Bone mass effects of a BMP4 gene polymorphism in postmenopausal women. Bone 36 (2005) 555-561
198. Ezura Y., Kajita M., Ishida R., Yoshida S., Yoshida H., Suzuki T., Hosoi T., Inoue S., Shiraki M., Orimo H., and Emi M. Association of multiple nucleotide variations in the pituitary glutaminyl cyclase gene (QPCT) with low radial BMD in adult women. J. Bone Miner. Res. 19 (2004) 1296-1301
199. Niu T., Chen C., Cordell H., Yang J., Wang B., Wang Z., Fang Z., Schork N.J., Rosen C.J., and Xu X. A genome-wide scan for loci linked to forearm bone mineral density. Hum. Genet. 104 (1999) 226-233
200. Devoto M., Shimoya K., Caminis J., Ott J., Tenenhouse A., Whyte M.P., Sereda L., Hall S., Considine E., Williams C.J., Tromp G., Kuivaniemi H., Ala-Kokko L., Prockop D.J., and Spotila L.D. First-stage autosomal genome screen in extended pedigrees suggests genes predisposing to low bone mineral density on chromosomes 1p, 2p and 4q. Eur. J. Hum. Genet. 6 (1998) 151-157
201. Mizuguchi T., Furuta I., Watanabe Y., Tsukamoto K., Tomita H., Tsujihata M., Ohta T., Kishino T., Matsumoto N., Minakami H., Niikawa N., and Yoshiura K. LRP5, low-density-lipoprotein-receptor-related protein 5, is a determinant for bone mineral density. J. Hum. Genet. 49 (2004) 80-86
202. Koay M.A., Woon P.Y., Zhang Y., Miles L.J., Duncan E.L., Ralston S.H., Compston J.E., Cooper C., Keen R., Langdahl B.L., MacLelland A., O'Riordan J., Pols H.A., Reid D.M., Uitterlinden A.G., Wass J.A., and Brown M.A. Influence of LRP5 polymorphisms on normal variation in BMD. J. Bone Miner. Res. 19 (2004) 1619-1627
203. Giroux S., Elfassihi L., Cardinal G., Laflamme N., and Rousseau F. LRP5 coding polymorphisms influence the variation of peak bone mass in a normal population of French-Canadian women. Bone 40 (2007) 1299-1307
204. Ezura Y., Nakajima T., Urano T., Sudo Y., Kajita M., Yoshida H., Suzuki T., Hosoi T., Inoue S., Shiraki M., and Emi M. Association of a single-nucleotide variation (A1330V) in the low-density lipoprotein receptor-related protein 5 gene (LRP5) with bone mineral density in adult Japanese women. Bone 40 (2007) 997-1005
205. Sobacchi C., Vezzoni P., Reid D.M., McGuigan F.E., Frattini A., Mirolo M., Albhaga O.M., Musio A., Villa A., and Ralston S.H. Association between a polymorphism affecting an AP1 binding site in the promoter of the TCIRG1 gene and bone mass in women. Calcif. Tissue Int. 74 (2004) 35-41
206. Laflamme N., Giroux S., Loredo-Osti J.C., Elfassihi L., Dodin S., Blanchet C., Morgan K., Giguere V., and Rousseau F. A frequent regulatory variant of the estrogen-related receptor alpha gene associated with BMD in French-Canadian premenopausal women. J. Bone Miner. Res. 20 (2005) 938-944
207. Ishida R., Emi M., Ezura Y., Iwasaki H., Yoshida H., Suzuki T., Hosoi T., Inoue S., Shiraki M., Ito H., and Orimo H. Association of a haplotype (196Phe/532Ser) in the interleukin-1-receptor-associated kinase (IRAK1) gene with low radial bone mineral density in two independent populations. J. Bone Miner. Res. 18 (2003) 419-423